HOPE IN PROGRESS: NEW RESEARCH UNDERWAY
From understanding levodopa induced dyskinesias to exploring environmental risk factors of PD, APDA-funded researchers launch cutting-edge studies
With someone diagnosed with PD every six minutes, scientific research is critical as we push for better treatments and ultimately, a cure. Devoted to our search for answers, APDA recently awarded $1.975 million to support innovative PD research for the 2023-2024 funding year.
The funded research projects will delve into key areas of PD biology including RNA regulation in levodopa-induced dyskinesia, cognitive impairment, underutilization of deep brain stimulation, and physical activity among Latino/a PD patients; as well as the clinical subtypes of PD, SARS-CoV-2 induced dopamine neuron damage, and so much more.
“APDA is steadfast in its research focus — identifying and supporting researchers early in their careers to encourage them to either commence or continue dedicating themselves to PD research, as well as helping established investigators pursue new and novel ideas.”
— Leslie A. Chambers, APDA President & CEO
Twenty grants have been awarded and include Post-Doctoral Fellowships, Diversity in PD Research grants, the George C. Cotzias Memorial Fellowship (APDA’s most prestigious award), and more.
We invite you to learn more about these grantees and browse all APDA-funded research.